Mapping large numbers of results may take a few moments.
Search Results
Showing 251 - 300 of 396 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Mycologics | Activity: Research and Development | Company Description Mycologics develops green antimicrobials to safeguard food, feed, and health from harmful fungal pathogens and their toxins (mycotoxins). | Location Durham | |
Company Mycosynthetix Inc. | Activity: Research and Development | Company Description Mycosynthetix manages a large collection of fungal isolates and discovers novel fungal metabolites for human and animal health and compounds for agricultural applications. | Location Hillsborough | |
Company Mycovia Pharmaceuticals Inc. | Activity: Research and Development | Company Description Mycovia Pharmaceuticals is developing therapies to treat yeast and fungal infections. | Location Durham | |
Company Myodenovo | Activity: Research and Development | Company Description Myodenovo is developing cultivated meat products. | Location Durham | |
Company NabGen Inc. | Activity: Research and Development | Company Description NabGen has developed a universal antibody suppressant technology to inhibit anti-drug and autoimmune antibodies, including suppression of pre-existing immunity and re-administration barriers to gene therapies based on adeno-associated virus (AAV) vectors. | Location Durham | |
Company Nelum Corp. | Activity: Research and Development | Company Description Nelum is a clinical-stage biopharmaceutical company developing patented drugs through an in-license process. Nelum´s focus is in oncology and fibrotic indications. | Location Cary | |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill | |
Company New Hope Biodiagnostics LLC | Activity: Research and Development | Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. | Location Chapel Hill | |
Company Nicox Ophthalmics | Activity: Research and Development | Company Description Nicox Ophthalmics develops therapeutics from a proprietary nitric-oxide research platform to help maintain vision and improve ocular health. | Location Durham | |
Company NIRvana Sciences Inc. | Activity: Research and Development | Company Description NIRvana Sciences is commercializing red and near-infrared fluorescent dyes for use in diagnostics and imaging applications. | Location Research Triangle Park | |
Company Novonesis BioAg | Activity: Research and Development | Company Description Novonesis BioAg develops microbial-based biofertility, biocontrol and bioyield enhancer products for agriculture. The Morrisville site focuses on fermentation and production technology. | Location Morrisville | |
Company Nufarm Americas Inc. | Activity: Research and Development | Company Description Nufarm manufactures and markets insecticides, fungicides, plant growth regulators and herbicides. This site serves as Nufarm's primary research and development facility in the United States. | Location Morrisville | |
Company NuPulseCV | Activity: Research and Development | Company Description NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure. | Location Raleigh | |
Company NuRevelation LLC | Activity: Research and Development | Company Description NuRevelation develops drug delivery methods for pharmaceuticals, nutraceuticals and cannabinoids. | Location Durham | |
Company Oerth Bio LLC | Activity: Research and Development | Company Description Oerth Bio is supporting crop protection, crop health, and healthy food by leveraging PROTAC® protein degrades, which work by harnessing the plant's own natural protein disposal system to degrade and remove unwanted proteins. | Location Durham | |
Company Oncotect | Activity: Research and Development | Company Description Oncotect is a chemical and biomolecular diagnostic company developing technology for the early detection of cancer in dogs. | Location Raleigh | |
Company Oncurie Inc. | Activity: Research and Development | Company Description Oncurie is developing a cure for metastatic cancer through the use of novel molecular radionuclide technology. | Location Raleigh | |
Company OnSite Remediation LLC | Activity: Research and Development | Company Description OnSite Remediation develops and uses naturally-occurring microbes, mechanical separators, coalescing units and filtration systems for the removal of contaminants from water and soil. | Location Cary | |
Company Opus Genetics Inc. | Activity: Research and Development | Company Description Opus Genetics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. | Location Research Triangle Park | |
Company OsteoCure Therapeutics Inc. | Activity: Research and Development | Company Description OsteoCure Therapeutics develops novel treatments to accelerate and promote bone fracture healing and prevent nonunions. | Location Durham | |
Company Outbreaks Inc. | Activity: Research and Development | Company Description Outbreaks produces over-the-counter homeopathic solutions for cold sores and other ailments that cause uncomfortable outbreaks. | Location Cary | |
Company Pairwise | Activity: Research and Development | Company Description Pairwise develops new varieties of crops by developing genome editing tools, leveraging plants' natural genetic diversity, and creating partnerships and collaborations with agriculture companies. | Location Durham | |
Company Panafina LLC | Activity: Research and Development | Company Description Panafina is developing a product for acute severe pancreatitis. | Location Morrisville | |
Company Parion Sciences Inc. | Activity: Research and Development | Company Description Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory diseases. | Location Durham | |
Company Path BioAnalytics Inc. | Activity: Research and Development | Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. | Location Durham | |
Company Pathalys Pharma Inc. | Activity: Research and Development | Company Description Pathalys Pharma develops therapeutics that address unmet needs in the management of end stage kidney disesase (ESKD). | Location Raleigh | |
Company Pathfinder Pharmaceuticals Inc. | Activity: Research and Development | Company Description Pathfinder Pharmaceuticals specializes in early stage drug discovery with a focus on cancer therapy. | Location Durham | |
Company Perfusio | Activity: Research and Development | Company Description Perfusio is developing, manufacturing and marketing platform technology for non-invasive surgical imaging that enables the providers to see real-time images of blood flow distribution and tissue perfusion without patient contact or injection of dye. | Location Greenville | |
Company Pertinent Eco-Solutions | Activity: Research and Development | Company Description Pertinent Eco Solutions has developed pest control products consisting of plant-derived active ingredients to replace traditional chemical pesticides. | Location Research Triangle Park | |
Company Pfizer (Morrisville) | Activity: Research and Development | Company Description Pfizer (Morrisville) develops robust, scalable and compliant processes for manufacture of biologics (gene therapies, multispecific antibodies, and complex proteins) and conducts analytical testing for drug substance manufacture. | Location Morrisville | |
Company Pfizer Inc. (Durham) | Activity: Research and Development | Company Description Pfizer develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases. Pfizer's BioTherapeutics Pharmaceutical Sciences site in Durham houses clinical manufacturing space and analytical research development laboratories. | Location Durham | |
Company PHAXTEC Inc. | Activity: Research and Development | Company Description PHAXTEC is an advanced materials start-up commercializing and marketing novel natural materials based on PolyHydroxyAlkanoates (PHA) that are recyclable, marine biodegradable and home & industrially compostable. | Location Wake Forest | |
Company PhosphoGam Inc. | Activity: Research and Development | Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. | Location Durham | |
Company PhotoCide Protection Inc. | Activity: Research and Development | Company Description PhotoCide Protection develops self-disinfecting materials based on technology combining engineered cellulose with photosensitizers which emit singlet oxygen, an environmentally-friendly biocidal agent which destroys pathogens on surfaces. | Location Apex | |
Company Pinnacle Hill LLC | Activity: Research and Development | Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. | Location Chapel Hill | |
Company Plant Health Care Inc. | Activity: Research and Development | Company Description Plant Health Care develops and provides novel biological products and technologies to promote plant health and increase crop yields. | Location Holly Springs | |
Company Plant Pathways Inc. (Sanford) | Activity: Research and Development | Company Description The Plant Pathways Company, a plant breeding company specializing in improving crops, breeds new variety of stevia as a natural sweetener and sugar substitute. | Location Sanford | |
Company Polaris QB Inc. | Activity: Research and Development | Company Description POLARISqb uses emerging biological data, cloud and quantum computing and artificial intelligence to produce drug blueprints to speed the lead time for preclinical drug candidates. | Location Durham | |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park | |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Durham | |
Company Priovant Therapeutics | Activity: Research and Development | Company Description Priovant is developing and commercializing targeted therapeutics for patients with severe autoimmune disease. | Location Durham | |
Company Pruvyc Pharma LLC | Activity: Research and Development | Company Description Pruvyc Pharma is developing a method for treating pruritus. | Location Cary | |
Company Qatch Technologies LLC | Activity: Research and Development | Company Description QATCH develops a microfluidic viscometer that screens injectability and manufacturability of biopharmaceutical formulations in preclinical drug development. | Location Durham | |
Company QuatroBio LLC | Activity: Research and Development | Company Description QuatroBio provides oversight and strategic direction to several closely held drug development companies. | Location Morrisville | |
Company Qura Therapeutics LLC | Activity: Research and Development | Company Description Qura Therapeutics is discovering therapeutics for curing HIV/AIDS. Qura is a joint venture between ViV Healthcare and UNC-CH and provides financial, material and development support for therapies that emerge from research at the UNC HIV Cure Center. | Location Chapel Hill | |
Company RainBio Inc. | Activity: Research and Development | Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. | Location Raleigh | |
Company Reactive Biosciences Inc. | Activity: Research and Development | Company Description Reactive Biosciences uses a boron-based discovery platform to discover and develop new medicines. | Location Durham | |
Company READDI Inc. | Activity: Research and Development | Company Description Rapidly Emerging Antiviral Drug Development Initiative (READDI) is a public-private partnership that develops broad-spectrum antiviral therapies for COVID-19 and other emerging viral threats. | Location Chapel Hill | |
Company Regennova Inc. | Activity: Research and Development | Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. | Location Durham | |
Company Relevant Biosciences Inc. | Activity: Research and Development | Company Description Relevant Bio develops natural antibody-based cancer therapeutics. | Location Raleigh |